Infrapopliteal 3-Vessel Occlusive Disease Is the Only Predictor of Wound Recurrence After Complete Wound Healing via Endovascular Therapy in Patients With Chronic Limb-threatening Ischemia

Abstract

Purpose:

To determine the predictors of wound recurrence after complete wound healing in patients with chronic limb-threatening ischemia (CLTI) who underwent endovascular therapy (EVT) for infrapopliteal (IP) lesions with consideration of IP arterial anatomic severity, including classification by the Global Limb Anatomic Staging System (GLASS).

Materials and Methods:

This retrospective single-center study assessed patients with de novo CLTI limbs with tissue loss treated via EVT for IP lesions from September 2016 to May 2021. Among these patients, 149 consecutive limbs from 133 patients who achieved complete wound healing were enrolled. The Kaplan-Meier method was used to estimate the wound recurrence rate after complete wound healing. The Cox proportional hazard model was used to assess the association between baseline characteristics and wound recurrence.

Results:

The cumulative wound recurrence rate 1 year after complete wound healing was 30%. The mean time for wound recurrence was 7±5 months. Only IP arterial anatomic characteristics remained as a predictor of wound recurrence, whereas wound status and management, including the Wound, Ischemia, and foot Infection (WIfI) clinical stage and minor amputation, were not associated with wound recurrence. Multivariate analysis revealed independent associations between wound recurrence and IP 3-vessel occlusive disease (hazard ratio, 2.97; 95% confidence interval, 1.39–6.35), but not poor below-the-ankle runoff, IP Peripheral Arterial Calcium Scoring System (PACSS) grade, and the GLASS IP grade.

Conclusion:

The only independent predictor of wound recurrence after complete wound healing via EVT in patients with CLTI was IP 3-vessel occlusive disease.

Clinical Impact

In patients with chronic limb-threatening ischemia (CLTI), wound recurrence after complete wound healing remains a challenge, and studies focused exclusively on wound recurrence are still limited. The present study aimed to determine the risk factors for wound recurrence after complete wound healing in patients with CLTI who underwent endovascular therapy (EVT) for infrapopliteal (IP) lesions, with consideration of IP arterial anatomic severity for the first time. The results showed that IP 3-vessel occlusive disease was the only predictor of wound recurrence, whereas wound status/management and other arterial anatomic characteristics including WIfI clinical stages and GLASS grades were not predictors.

Keywords

chronic limb-threatening ischemia critical limb ischemia wound recurrence endovascular therapy Global Limb Anatomic Staging System infrapopliteal arteries

Get full access to this article

View all access options for this article.

References

Aboyans

Ricco

Bartelink

MEL

, et al. Editor’s choice—2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55(3):305–368. doi:10.1016/j.ejvs.2017.07.018.

Romiti

Albers

Brochado-Neto

, et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47(5):975–981. doi:10.1016/j.jvs.2008.01.005.

Söderström

Arvela

Korhonen

, et al. Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia: a propensity score analysis. Ann Surg. 2010;252(5):765–773. doi:10.1097/SLA.0b013e3181fc3c73.

Rocha-Singh

Jaff

Joye

, et al. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL Trial. Catheter Cardiovasc Interv. 2012;80(6):1042–1051. doi:10.1002/ccd.24485.

Kawarada

Fujihara

Higashimori

, et al. Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv. 2012;80(5):861–871. doi:10.1002/ccd.24370.

Iida

Nakamura

Yamauchi

, et al. Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up. Circ Cardiovasc Interv. 2013;6(1):68–76. doi:10.1161/CIRCINTERVENTIONS.112.975318.

Conte

Bradbury

Kolh

, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S–125S. doi:10.1016/j.jvs.2019.02.016.

Rocha-Singh

Zeller

Jaff

MR.

Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83:E212–E220. doi:10.1002/ccd.25387.

Iida

Nakamura

Yamauchi

, et al. 3-year outcomes of the OLIVE registry, a prospective multicenter study of patients with critical limb ischemia: a prospective, multi-center, three-year follow-up study on endovascular treatment for infra-inguinal vessel in patients with critical limb ischemia. JACC Cardiovasc Interv. 2015;8(11):1493–1502. doi:10.1016/j.jcin.2015.07.005.

10.

El Khoury

Edwards

, et al. The global limb anatomic staging system is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia. J Vasc Surg. 2021;73(6):2009–2020.e4. doi:10.1016/j.jvs.2020.12.094.

11.

Kodama

Meecham

Popplewell

, et al. Editor’s choice—relationship between global limb anatomic staging system (GLASS) and clinical outcomes following revascularisation for chronic limb threatening ischaemia in the bypass versus angioplasty in severe ischaemia of the leg (BASIL)-1 trial. Eur J Vasc Endovasc Surg. 2020;60(5):687–695. doi:10.1016/j.ejvs.2020.06.042.

12.

Tokuda

Oba

Koshida

, et al. Validation of Global Limb Anatomical Staging System (GLASS) in patients with hemodialysis and chronic limb-threatening ischemia after endovascular treatment. Heart Vessels. 2021;36(6):809–817. doi:10.1007/s00380-020-01747-1.

13.

Hata

Iida

Takahara

, et al. Infrapopliteal anatomic severity and delayed wound healing in patients with chronic limb-threatening ischemia in the era of the global limb anatomic staging system. J Endovasc Ther. 2020;27(4):641–646. doi:10.1177/1526602820933880.

14.

Tokuda

Oba

Koshida

, et al. Prediction of the technical success of endovascular therapy in patients with critical limb threatening ischaemia using the global limb anatomical staging system. Eur J Vasc Endovasc Surg. 2020;60(5):696–702. doi:10.1016/j.ejvs.2020.05.003.

15.

Schmidt

Ulrich

Winkler

, et al. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv. 2010;76(7):1047–1054. doi:10.1002/ccd.22658.

16.

Iida

Soga

Kawasaki

, et al. Angiographic restenosis and its clinical impact after infrapopliteal angioplasty. Eur J Vasc Endovasc Surg. 2012;44(4):425–431. doi:10.1016/j.ejvs.2012.07.017.

17.

Mills

Sr Conte

Armstrong

, et al. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on Wound, Ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59(1):220–234.e1. doi:10.1016/j.jvs.2013.08.003.

18.

Nakama

Watanabe

Haraguchi

, et al. Clinical outcomes of pedal artery angioplasty for patients with ischemic wounds: results from the multicenter RENDEZVOUS registry. JACC Cardiovasc Interv. 2017;10(1):79–90. doi:10.1016/j.jcin.2016.10.025.

19.

Utsunomiya

Takahara

Iida

, et al. Limb-based patency after surgical vs endovascular revascularization in patients with chronic limb-threatening ischemia. J Endovasc Ther. 2020;27(4):584–594. doi:10.1177/1526602820923388.

20.

Almasri

Adusumalli

Asi

, et al. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. J Vasc Surg. 2018;68(2):624–633. doi:10.1016/j.jvs.2018.01.066.

21.

Jongsma

Bekken

Akkersdijk

, et al. Angiosome-directed revascularization in patients with critical limb ischemia. J Vasc Surg. 2017;65(4):1208–1219.e1. doi:10.1016/j.jvs.2016.10.100.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

2.64 MB

1.98 MB